Cupid Limited Signals Strong Q2 FY27 Momentum; Raises FY27 Revenue & Profit Guidance October 8, 2026 Q2 FY27 Revenue Expected to Cross ₹200 Cr; FY27 Revenue Guidance Raised to ₹800+ Cr & Net Profit Guidance to ₹250+ Cr Mumbai (Maharashtra)… Continue Reading
Cupid Limited Highlights Strong FY26 Performance & Expanding Growth Platform at 33rd AGM September 24, 2026 Mr. Aditya Kumar Halwasiya outlines FY27 guidance of ₹725–750 crore revenue and ₹210–225 crore net profit; highlights consumer growth, Palava capacity expansion, global healthcare… Continue Reading
Cupid Limited Surpasses FY26 Guidance With Record Revenue Growth of 93 Percent YoY and Net Profit Growth of 165 Percent YoY May 18, 2026 Mumbai (Maharashtra) [India], May 18: Cupid Limited (Cupid, The Company) announced its strongest-ever quarterly performance in Q4 FY26 (quarter ended 31st March 2026), driven by strong… Continue Reading
Cupid Limited Announces Record Date for 4:1 Bonus Issue March 3, 2026 Mumbai (Maharashtra) [India], March 03: Cupid Limited (BSE: 530843 | NSE: CUPID) has announced the issue and allotment of Bonus Equity Shares in the ratio… Continue Reading
Cupid Limited Appoints Former BHEL CMD Mr. Bontha Prasada Rao as Independent Director February 26, 2026 Mumbai (Maharashtra) [India], February 26: Cupid Limited (Cupid, The Company),has appointed Mr. Bontha Prasada Rao (DIN: 01705080) as an Additional Non-Executive Independent Director of… Continue Reading
Aditya Kumar Halwasiya strengthens his stake in Cupid Limited, reaffirming strong promoter confidence in the company’s long-term growth February 9, 2026 Mumbai (Maharashtra) [India], February 09: Cupid Limited (Cupid, The Company), Mr. Aditya Kumar Halwasiya, Chairman and Managing Director of Cupid Limited, has increased his… Continue Reading
Cupid Limited Receives CE (EU IVDR) Certification for HIV 1&2 and Hepatitis B IVD Test Kits, Expanding Global Market Access in Diagnostics January 30, 2026 Cupid Limited, (BSE – 530843, NSE – CUPID), a diversified Indian healthcare and consumer products company with a growing focus on in-vitro diagnostics (IVD),wellness, and… Continue Reading
Cupid Limited Delivers Record Q3 FY26 Performance with 201 percent YoY Growth in EBITDA January 30, 2026 Mumbai (Maharashtra) [India], January 30: Cupid Limited (Cupid, The Company), announced that it delivered the strongest quarter in its history during Q3 FY26 (quarter ended 31 December… Continue Reading
